Galler, Samuel B.

HRN: 26-51-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2025
01/24/2025
IV
500mg
Q8H
Cholecystitis
Waiting Final Action 
01/17/2025
CEFTRIAXONE 1G (VIAL)
01/17/2025
01/24/2025
IVTT
2g
OD
Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: